NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Clinical trials for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chinese patients with spinal arthritis: phase 3 drug trial shows promise
Disease control CompletedThis study tested a drug called secukinumab in 137 Chinese adults with a type of spinal arthritis (non-radiographic axial spondyloarthritis) that causes back pain and stiffness. The goal was to see if the drug improves symptoms more than a placebo after 16 weeks, and to check its…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New study reveals how long patients stay on secukinumab for skin and joint conditions
Knowledge-focused CompletedThis completed study followed 127 adults with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis who were already taking or starting secukinumab. Researchers observed them for two years to see how long the…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC